![Kenneth F. Boehm](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth F. Boehm
No open positions remaining
Profile
Kenneth F.
Boehm held several positions in human resources throughout his career.
He started as the Vice President-Human Resources at Synopsys, Inc. from 2010 to 2013.
He then worked as the Senior Vice President-Human Resources at Pharmacyclics LLC.
In 2013, he became the Vice President-Human Resources at Polycom, Inc. until 2014.
From 2014 to 2015, he served as the Senior Vice President-Human Resources at E2open LLC.
Mr. Boehm also worked as the Vice President-Human Resources at Gilead Sciences, Inc. from 2009 to 2020.
Prior to that, he was the Vice President-Human Resource at PalmSource, Inc. from 2002 to 2005 and the Vice President-Human Resources at CV Therapeutics, Inc. from 2005 to 2009.
He later became the Vice President-Human Resources at Aimmune Therapeutics, Inc. from 2015 to 2018.
Currently, he is the Senior Vice President-Human Resources at CymaBay Therapeutics, Inc. from 2019 to 2024.
Mr. Boehm obtained his undergraduate degree from the University of California, Los Angeles.
He also holds a doctorate degree from Golden Gate University and an MBA from Pepperdine University.
Former positions of Kenneth F. Boehm
| Companies | Position | End |
|---|---|---|
| CYMABAY THERAPEUTICS, INC. | Human Resources Officer | 2024-03-21 |
| GILEAD SCIENCES, INC. | Human Resources Officer | 2020-04-30 |
| AIMMUNE THERAPEUTICS, INC. | Human Resources Officer | 2018-03-31 |
| E2OPEN INC | Human Resources Officer | 2015-07-31 |
| POLYCOM INC | Human Resources Officer | 2014-04-30 |
Training of Kenneth F. Boehm
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
90
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Synopsys, Inc.
 Synopsys, Inc. Packaged SoftwareTechnology Services Develops semiconductor intellectual property and electronic design automation software solutions | Technology Services |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Polycom, Inc.
 Polycom, Inc. Electronics/AppliancesConsumer Durables Provides solutions for video, voice, data and web communication | Consumer Durables |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
PalmSource, Inc.
 PalmSource, Inc. Packaged SoftwareTechnology Services Develops and licenses platform software | Technology Services |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Golden Gate University
 Golden Gate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pepperdine University
 Pepperdine University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
E2open LLC
 E2open LLC Packaged SoftwareTechnology Services Develops cloud-based supply chain platform | Technology Services |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
- Stock Market
- Insiders
- Kenneth F. Boehm
